Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity

References

• Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and non-steroidal anti-inflammatory drugs. N Engl J Med 1994;331:1675–9
   PubMed Web of Science ®Google Scholar
• Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972;240:410–11
   PubMed Web of Science ®Google Scholar
• Bertolini A, Ottani A, Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr Med Chem 2002;9:1033–43
   PubMed Web of Science ®Google Scholar
• Zygmunt PM, Chuang H, Movahed P. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000;396:39–42
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ. The Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364–72
   PubMed Web of Science ®Google Scholar
• Teresita G, Alejandra ER, Américo OJ, Lilian EP. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il Farmaco 2001;56:683–7
   PubMedGoogle Scholar
• Janbaz KH, Saeed SA, Gilani AH. Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents. Phytomedicine 2004;11:424–30
   PubMed Web of Science ®Google Scholar
• Renugadevi J, Milton PS. Quercetin protects against oxidative stress-related renal dysfunction by cadmium in rats. Exp Toxicol Pathol 2010;62:471–8
   PubMed Web of Science ®Google Scholar
• Camila AC, Simone CB, Eduardo BS. Quercetin as an inhibitor of snake venom secretory phospholipase A2. Chem Biol Interact 2011;189:9–16
   PubMed Web of Science ®Google Scholar
• Xiangsheng X, Dingbo S, Liqun L, et al. Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One 2011;6:e229–34
   Google Scholar
• Chaudhuri S, Banerjee A, Basu K, et al. Interaction of flavonoids with red blood cell membrane lipids and proteins: antioxidant and antihemolytic effects. Int J Biol Macromol 2007;41:42–8
   PubMed Web of Science ®Google Scholar
• Sathiavelu J, Senapathy GJ, Devaraj R, Namasivayam N. Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats. J Pharm Pharmacol 2009;61:809–17
   PubMed Web of Science ®Google Scholar
• Sarwat S, Kriti V, Rehan K. Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress. J Pharm Pharmacol 2012;64:872–81
   PubMed Web of Science ®Google Scholar
• Ha SK, Moon E, Kim SY. Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-kappa B and JNK activations in microglia cells. Neurosci Lett 2010;485:143–7
   PubMed Web of Science ®Google Scholar
• Venkatesh RC, Ravindra BP, Siva RC, et al. Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm 2013;39:865–72
   PubMed Web of Science ®Google Scholar
• Tripathi YB, Tiwari OP, Santosh N, Mishra B. Pharmacokinetic-interaction of Vitex negundo Linn. & paracetamol. Indian J Med Res 2009;130:479–83
   PubMed Web of Science ®Google Scholar
• Sudhir NU, Pankaj VD, Vijendra K, et al. Quercetin pretreatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition. Biochem Pharmacol 2008;75:1670–6
   PubMed Web of Science ®Google Scholar
• Shih HF, Yu CH, Pei DLC. Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporine. Toxicol Appl Pharmacol 2005;205:65–70
   PubMed Web of Science ®Google Scholar
• Yunju B, Soyoung L, Sang HK. Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB. Toxicol Appl Pharmacol 2011;254:56–64
   PubMed Web of Science ®Google Scholar
• Qiongfeng L, Zhiyong X, Biyan P, et al. LC–MS–MS simultaneous determination of paracetamol, pseudoephedrine and chlorpheniramine in human plasma: application to a pharmacokinetic study. Chromatographia 2008;67:687–94
   Web of Science ®Google Scholar
• Jan J, Jiri K, Lucia ZZ, Josef T. Simultaneous HPLC determination of tolbutamide, phenacetin and theirmetabolites as markers of cytochromes 1A2 and 2C6/11 in rat liver perfusate. J Pharm Biomed Anal 2010;52:557–64
   PubMed Web of Science ®Google Scholar
• Carmen FP, Juan LP, Blanca RM, et al. A reliable method of liquid chromatography for the quantification of acetaminophen and identification of its toxic metabolite N-acetyl-p-benzoquinoneimine for application in pediatric studies. Biomed Chromatogr 2011;25:760–6
   PubMed Web of Science ®Google Scholar
• Ravindra BP, Naveen BK, Haroled PL, et al. Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models. Drug Dev Ind Pharm 2013;39:873–9
   PubMed Web of Science ®Google Scholar
• Wynne HA, Campbell M. Pharmacoeconomics of non-steroidal anti inflammatory drugs (NSAIDS). Pharmacoeconomics 1993;3:107–23
   PubMedGoogle Scholar
• Wu CY, Benet LZ, Hebert MF, et al. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther 1995;58:492–7
   PubMed Web of Science ®Google Scholar
• Barry HR. Acetaminophen misconceptions. Hepatology 2004;40:10–15
   PubMed Web of Science ®Google Scholar
• Detlef S, Ji DJ, Benno B, Eckhart GH. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999;30:1099–104
   PubMed Web of Science ®Google Scholar
• Izzo AA. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 2005;19:1–16
   PubMed Web of Science ®Google Scholar
• Yasutake M, Narumi S, Koji F. Inhibitory effect of flavonoids on sulfo- and glucurono-conjugation of acetaminophen in rat cultured hepatocytes and liver subcellular preparations. Biol Pharm Bull 2004;27:714–17
   PubMed Web of Science ®Google Scholar
• Androutsopoulos VP, Papakyriakou A, Vourloumis D, et al. Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes. Pharmacol Ther 2010;126:9–20
   PubMed Web of Science ®Google Scholar
• Tang Y, Tian H, Shi Y, et al. Quercetin suppressed CYP2E1-dependent ethanol hepatotoxicity via depleting heme pool and releasing CO. Phytomedicine 2013;20:699–704
   PubMed Web of Science ®Google Scholar
• Shriner K, Goetz MB. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med 1992;93:94–6
   PubMed Web of Science ®Google Scholar
• Sang KL, Sudeep RB, Hemin J, et al. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats. Arch Pharm Res 2007;30:1629–34
   PubMed Web of Science ®Google Scholar
• Kamali F. The effect of probenecid on paracetamol metabolism and pharmacokinetics. Eur J Clin Pharmacol 1993;45:551–3
   PubMed Web of Science ®Google Scholar
• Lin H, Fan H, Huichang B, et al. Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations. Bioorg Med Chem Lett 2010;20:6008–12
   PubMed Web of Science ®Google Scholar
• Tahir M, Sultana S. Chrysin modulates ethanol metabolism in Wistar rats: a promising role against organ toxicities. Alcohol Alcohol 2011;46:383–92
   PubMed Web of Science ®Google Scholar
• Irena M, Yulia B, Anat EW, et al. High-dose acetaminophen inhibits the lethal effect of doxorubicin in HepG2 cells: the role of P-glycoprotein and mitogen-activated protein kinase p44/42 pathway. J Pharmacol Exp Ther 2007;322:1013–22
   PubMed Web of Science ®Google Scholar
• Carolina IG, Agostina A, Silvina V, et al. Induction of intestinal P-glycoprotein (P-gp) expression and activity by sub-toxic doses of acetaminophen (AP) in rat intestine and human LS174T cells. FASEB J 2010;24:758.5
   Google Scholar
• Alfio B, Anna F, Alessandra O, et al. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006;12:250–75
   PubMedGoogle Scholar
• Astha M, Ginpreet K, Meena C. Piperine and quercetin enhances antioxidant and hepatoprotective effect of curcumin in paracetamol induced oxidative stress. Int J Pharmacol 2012;8:101–7
   Web of Science ®Google Scholar
• Kandaswami C, Middleton E. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 1994;366:351–76
   PubMedGoogle Scholar